The company develops a novel, cell-based medicine as a treatment for chemotherapy, radiation-induced neutropenia and for acute radiation syndrome.
http://reports.pr-inside.com/new-market-study-published-cellerant-therapeutics-r3746051.htm
http://reports.pr-inside.com/new-market-study-published-cellerant-therapeutics-r3746051.htm
No comments:
Post a Comment